XML 34 R23.htm IDEA: XBRL DOCUMENT v3.25.3

Stockholders’ Equity (Tables)

9 Months Ended

Sep. 30, 2025

Equity [Abstract]

Schedule of Grant Date Fair Value of Stock Options Issued

The significant inputs utilized to determine the grant date fair value of stock options issued during the nine month periods ended September 30, 2025 and 2024 were as follows:

 Schedule of Grant Date Fair Value of Stock Options Issued

		September 30,				September 30,
		2025				2024
Dividend Yield			0	%			0	%
Weighted average expected term (years)			5.38-6.00				5.75-6
Volatility			65.68-101.98	%			97.3-105.8	%
Risk-free rate			3.86-4.18	%			4.10	%
Weighted average exercise price		$	0.97			$	1.33

Schedule of Stock Option Activity

A summary of stock option activity for the nine months ended September 30, 2025 is presented below:

 Schedule of Stock Option Activity

		Number of Options				Weighted Average Exercise Price				Weighted Average Contractual Term (Years)				Aggregate Intrinsic Value
Outstanding as of December 31, 2024			10,633,988				1.02				6.25			$	102,921,147
Granted			1,092,105				1.16
Exercised			-				-
Forfeited			-				-
Outstanding as of September 30, 2025			11,726,093			$	1.03				5.68			$	8,533,901
Exercisable as of September 30, 2025			10,814,635			$	1.02				5.33			$	7,994,141

Schedule of Employee Stock Options Outstanding

The following table summarizes information related to stock options outstanding as of September 30, 2025:

 Schedule of Employee Stock Options Outstanding

					Outstanding Options								Vested Options
	Exercise Price				Number Outstanding at September 30, 2025				Weighted Average Remaining Life				Number Exercisable at September 30, 2025				Weighted Average Remaining Life
$	0.01				675,000				0.25				675,000				0.25
$	0.74				1,657,564				3.32				1,657,564				3.32
$	0.80				2,783,239				3.54				2,783,239				3.54
$	0.97				250,000				9.67				86,968				9.67
$	1.19				357,448				9.76				-				-
$	1.23				484,657				9.94				93,689				9.94
$	1.33				5,461,935				7.33				5,461,925				7.33
$	2.16				56,250				5.71				56,250				5.71
					11,726,093				5.68				10,814,635				5.33

Schedule of Warrant Activity

The following is a summary of the Company’s warrant activity for the nine months ended September 30, 2025:

 Schedule of Warrant Activity

		Number of Shares				Weighted Average Exercise Price per Share				Weighted Average Remaining Life (Years)
Outstanding as of December 31, 2024			1,359,375			$	0.80				0.93
Exercised			(1,359,375	)			0.80				-
Forfeited			-				-				-
Outstanding as of September 30, 2025			-			$	-				-

X

- Definition

Schedule of Share Based Compensation Warrant Activity [Table Text Block]

+ References

No definition available.

+ Details

Name:	JUNS_ScheduleOfShareBasedCompensationWarrantActivityTableTextBlock
Namespace Prefix:	JUNS_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	us-gaap_EquityAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of option exercise prices, by grouped ranges, including the upper and lower limits of the price range, the number of shares under option, weighted average exercise price and remaining contractual option terms.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

+ Details

Name:	us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (d)
-SubTopic 10
-Topic 718
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (e)
-SubTopic 10
-Topic 718
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

+ Details

Name:	us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the weighted-average grant-date fair value of equity options or other equity instruments granted during the year.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (d)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

+ Details

Name:	us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration